N Dauletbaev, K Viel, R Buhl, T.O.F Wagner, J Bargon

Slides:

Advertisements

Similar presentations

The prevalence of “risky behaviour” in adults with cystic fibrosis

Advertisements

Monocyte chemoattractant chemokines in cystic fibrosis

Treatment compliance in children and adults with Cystic Fibrosis

Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus Magnus Hillman, Leif Eriksson, Lena Mared, Karin Helgesson,

P. Whitaker, N. Shaw, J. Gooi, C. Etherington, S. Conway, D. Peckham

Development, validation, and implementation of a questionnaire assessing disease knowledge and understanding in adult cystic fibrosis patients Karen.

Use of high-dose ibuprofen in a pediatric cystic fibrosis center

Abaigeal D. Jackson, Christopher H. Goss Journal of Cystic Fibrosis

Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection—A.

H. Grasemann, E. Tullis, F. Ratjen Journal of Cystic Fibrosis

Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H

Development of a quantitative immunofluorescence assay for detection of Stenotrophomonas maltophilia antibodies in patients with cystic fibrosis P. Gonçalves.

Pseudomonas aeruginosa in cystic fibrosis: Pyocyanin negative strains are associated with BPI-ANCA and progressive lung disease Malin Carlsson, Swati.

Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study Doug L. Forrester, Alan J. Knox,

Microbiological yield from induced sputum compared to oropharyngeal swab in young children with cystic fibrosis Marco Zampoli, Komala Pillay, Henri Carrara,

Laura Viviani, Baroukh M. Assael, Eitan Kerem

Statistical limitations of percent ideal body weight as measure for nutritional failure in patients with cystic fibrosis T.O. Hirche, H. Hirche, S. Jungblut,

Cirrhosis and other liver disease in cystic fibrosis

Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin

Rate of improvement of CF life expectancy exceeds that of general population— Observational death registration study Matthew N. Hurley, Tricia M. McKeever,

Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia P.Ø. Jensen, C. Moser, A. Kharazmi,

The applicability of urinary creatinine as a method of specimen normalization in the cystic fibrosis population Brandie D. Wagner, Frank J. Accurso,

Fiona K. Dunlevy, S. Lorraine Martin, Francine de Courcey, J

Controlled clinical trials in cystic fibrosis — are we doing better?

Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar

Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox

Evaluation of salt supplementation in CF infants

Comparison of real time diagnostic chemistries to detect Pseudomonas aeruginosa in respiratory samples from cystic fibrosis patients J.L. Fothergill,

Ghrelin and leptin levels in young adults with cystic fibrosis: Relationship with body fat Charilaos Stylianou, Assimina Galli-Tsinopoulou, George Koliakos,

A.H. Gifford Journal of Cystic Fibrosis

M. Al-Aloul, M. Jackson, G. Bell, M. Ledson, M. Walshaw

Cystic fibrosis related diabetes in an extremely young patient

Inhalation solutions — Which ones may be mixed

Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor Meredith C. Fidler, Jack Beusmans, Paul Panorchan,

E. Tschiedel, H. Grasemann, F. Ratjen Journal of Cystic Fibrosis

Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?

Felix Ratjen, Florian Brockhaus, Gerhild Angyalosi

Depression and anxiety in adolescents and adults with cystic fibrosis in the UK: A cross- sectional study Alistair J.A. Duff, Janice Abbott, Carolyn Cowperthwaite,

Stenotrophomonas maltophilia in cystic fibrosis: Improved detection by the use of selective agar and evaluation of antimicrobial resistance P. Goncalves-Vidigal,

Nasal polyposis in lung transplant recipients with cystic fibrosis

Elliott C. Dasenbrook, Gregory S. Sawicki Journal of Cystic Fibrosis

Pharmacokinetics and sputum penetration of azithromycin during once weekly dosing in cystic fibrosis patients E.B. Wilms, D.J. Touw, H.G.M. Heijerman

Inflammatory and immunological biomarkers are not related to survival in adults with Cystic Fibrosis K.L. Moffitt, S.L. Martin, A.M. Jones, A.K. Webb,

Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis Geraint B. Rogers, Lucas R. Hoffman,

Theresa A. Laguna, Cynthia B. Williams, Kyle R

Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention H. White, K. Pollard, C. Etherington, I. Clifton,

Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005 F.A. Millar, N.J. Simmonds, M.E. Hodson Journal.

H. White, A.M. Morton, S.P. Conway, D.G. Peckham

J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer

Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis C. Calabrese, A. Tosco, P. Abete, V. Carnovale,

Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid

Michael W. Konstan, David J. Pasta, Jeffrey S. Wagener, Donald R

Antibiograms of resistant Gram-negative bacteria from Scottish CF patients F.M. MacKenzie, S.V. Smith, K.E. Milne, K. Griffiths, J. Legge, I.M. Gould

Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis Hanne Vebert Olesen, Uffe Holmskov, Peter Oluf Schiøtz, Grith Lykke Sørensen

Decreased interleukin-18 expression in BAL cells and peripheral blood mononuclear cells in adult cystic fibrosis patients Hans-Peter Hauber, Inga S Beyer,

C. R. Hansen, T. Pressler, K. G. Nielsen, P. Ø. Jensen, T

D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher

The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation C. Etherington,

CFTR modulators and pregnancy: Our work has only just begun

Ristan M. Greer, Helen M. Buntain, Peter J. Lewindon, Claire E

Beta-lactam allergy in adults with cystic fibrosis

Airway inflammation in mild cystic fibrosis

Brian S. Murphy, Heather M

CFTR, investigated with the two-electrode voltage-clamp technique: the importance of knowing the series resistance Georg Nagel Journal of Cystic Fibrosis

Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz Journal of Cystic Fibrosis

David Adeboyeku, Sandra Scott, Margaret E. Hodson

Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern?

Cystic fibrosis and pregnancy in the modern era: A case control study

R. D. Gray, M. Imrie, A. C. Boyd, D. Porteous, J. A. Innes, A. P

H. White, A.M. Morton, D.G. Peckham, S.P. Conway

Presentation transcript:

Glutathione and glutathione peroxidase in sputum samples of adult patients with cystic fibrosis N Dauletbaev, K Viel, R Buhl, T.O.F Wagner, J Bargon Journal of Cystic Fibrosis Volume 3, Issue 2, Pages 119-124 (June 2004) DOI: 10.1016/j.jcf.2004.03.005

Fig. 1 Glutathione levels in sputum samples of healthy (H), asthmatic (A), and CF individuals. In healthy and asthmatic individuals, sputum was induced by inhalation of 3% NaCl. CF patients provided spontaneous (CF spont.) and samples induced by 3% NaCl (CF ind.). The main graphic represents data of sputum total glutathione shown as individual values, median, and 25–75 percentiles. The smaller graphic shows median (25–75 percentiles) levels of sputum GSH expressed as percentage of total glutathione. Both total glutathione and GSH levels in CF sputum samples are significantly (p<0.001) higher than the levels in non-CF samples. Journal of Cystic Fibrosis 2004 3, 119-124DOI: (10.1016/j.jcf.2004.03.005)